Pilot Success Review Command
SCRIMED turns handoff evidence into reviewable 30/60/90-day success plans.
This command layer organizes pilot review questions, evidence gaps, expansion readiness, and claims-safe follow-up while keeping ROI, revenue, activation, clinical, payer, EHR, and PHI authority blocked.
Success review boundary
Review summaries can be prepared; outcome claims remain evidence-bound and human-reviewed.
SCRIMED Pilot Success Review Command converts synthetic pilot evidence, activation plans, and handoff packets into 30/60/90-day review plans, evidence-gap tracking, expansion readiness, and claims-safe follow-up. It does not authorize live PHI, autonomous clinical care, diagnosis, treatment, prescribing, patient outreach, payer submission, EHR writeback, production deployment, customer activation, audited financial reporting, ROI guarantees, revenue guarantees, profit guarantees, valuation assurance, binding commercial offers, certification claims, securities material, or legal/procurement approval.
01phiAuthority: not-authorized-production-phi
02clinicalCareAuthority: not-authorized-live-care
03financialAuthority: not-audited-financial-report
04roiAuthority: not-roi-guarantee
05revenueAuthority: not-revenue-guarantee
06commercialAuthority: not-binding-commercial-offer
07customerActivationAuthority: not-customer-go-live-approval
08externalDistributionAuthority: human-review-required
09legalAuthority: qualified-review-required
Review plans
Each review plan ties a time window, reviewer, evidence inputs, success signal, and blocked claim together.
Attach reviewer notes to the selected handoff packet, run the evidence-gap checklist, and prepare a claims-safe 30/60/90-day review summary before any buyer or investor distribution.
day-30 - workflow-value
30-day workflow-fit review
Did the synthetic pilot evidence map to a buyer-recognized workflow problem and owner path?
ready-for-review
- Reviewer: Delivery Lead + Buyer Sponsor
- Signal: Buyer confirms the workflow problem, owner, and next review milestone.
- Safe output: Workflow-fit readiness summary with evidence gaps and retained no-go boundaries.
- Blocked claim: No productivity, ROI, savings, or staffing reduction guarantee.
- Proof routes: /pilot-value-evidence, /pilot-activation-planner, /pilot-handoff-command
day-30 - security-governance
30-day security and governance review
Are data boundaries, security contacts, deployment assumptions, and questionnaire blockers documented?
external-approval-required
- Reviewer: Security + Data Governance
- Signal: Security reviewer confirms metadata-only discovery path or lists missing approvals.
- Safe output: Security readiness note with unresolved approval blockers.
- Blocked claim: No certification, live PHI authorization, production connector approval, or security guarantee.
- Proof routes: /pilot-handoff-command, /scrimed-cyber-defense, /clinical-data-governance
day-60 - buyer-adoption
60-day buyer adoption friction review
Which workflow, meeting, documentation, or owner bottlenecks are slowing pilot expansion?
ready-for-review
- Reviewer: Implementation Lead + Customer Success
- Signal: Friction points are owner-bound and queued with safe workarounds.
- Safe output: Adoption friction map and owner-bound action register.
- Blocked claim: No customer activation approval, patient outreach approval, or operational outcome guarantee.
- Proof routes: /pilot-handoff-command, /service-delivery, /client-onboarding
day-60 - clinical-governance
60-day clinical governance review
Does any buyer-facing language imply clinical authority beyond decision support?
blocked-before-claim
- Reviewer: Clinical Governance
- Signal: Clinical-facing language remains decision-support-only and reviewer-gated.
- Safe output: Clinical governance posture note with blocked authority claims.
- Blocked claim: No diagnosis, treatment, prescribing, triage, final imaging interpretation, or live-care claim.
- Proof routes: /pilot-handoff-command, /clinical-authority-readiness, /clinical-production-readiness
day-90 - commercial-readiness
90-day commercial readiness review
Is there enough reviewed evidence to propose a next scoped paid package without overclaiming outcomes?
review-required
- Reviewer: Founder + Commercial Operations + Qualified Review
- Signal: Next scoped package is framed as measurement and implementation work, not guaranteed ROI.
- Safe output: Claims-safe expansion readiness note and next package recommendation.
- Blocked claim: No binding commercial offer, ROI guarantee, revenue guarantee, valuation assurance, or legal approval.
- Proof routes: /healthcare-value-realization, /pilot-activation-planner, /pricing, /offerings
post-pilot - investor-diligence
Post-pilot investor proof review
Which route-backed proof artifacts can support investor diligence without becoming securities material?
review-required
- Reviewer: Founder + Qualified Reviewer
- Signal: Investor narrative references route-backed evidence and clearly separates readiness from claims.
- Safe output: Investor diligence appendix with proof routes, risks, and next milestones.
- Blocked claim: No securities material, investment advice, valuation assurance, or audited financial reporting.
- Proof routes: /pilot-handoff-command, /investor-audience-readiness, /investor-readiness, /risk-register
Evidence gaps
Evidence gaps block overclaims before buyer, investor, or expansion narratives are shared.
evidence-gap
Buyer reviewer notes are missing or not mapped to evidence packets.
Weakens buyer confidence and makes claims harder to defend.
Customer Success + Delivery Lead
- Workaround: Keep the outcome narrative internal until reviewer notes are attached.
- Proof route: /pilot-handoff-command
external-approval-required
Security questionnaire or data-boundary disposition is missing.
Blocks protected pilot progression and enterprise IT confidence.
Security + Data Governance
- Workaround: Run metadata-only security review and document unresolved external approvals.
- Proof route: /scrimed-cyber-defense
blocked-before-claim
Clinical-facing summary language may be interpreted as clinical authority.
Creates regulatory, safety, and buyer-trust risk.
Clinical Governance
- Workaround: Route through clinical governance and use decision-support-only language.
- Proof route: /clinical-authority-readiness
blocked-before-claim
Commercial summary uses outcome language without sufficient reviewed evidence.
Creates ROI, revenue, valuation, or customer-activation overclaim risk.
Commercial Operations + Qualified Review
- Workaround: Use measurement-framework language and hold expansion packet for qualified review.
- Proof route: /healthcare-value-realization
evidence-gap
Implementation owner, cadence, or escalation path is incomplete.
Slows pilot expansion and creates handoff ambiguity.
Implementation Lead
- Workaround: Resolve owner map before proposing any expansion step.
- Proof route: /client-onboarding
Expansion readiness
Expansion opportunities are framed as safe next steps, not guarantees or approvals.
ready-for-review
Expand from workflow discovery into a paid implementation sprint.
Reviewed 30/60-day evidence packet, buyer owner notes, and implementation cadence.
Founder + Delivery Lead
- Next: Prepare a scoped implementation sprint recommendation with qualified review.
- Blocked: No binding offer, ROI guarantee, staffing reduction claim, or customer activation approval.
- Proof routes: /pilot-activation-planner, /pilot-handoff-command, /healthcare-value-realization
external-approval-required
Move security questionnaire support into paid diligence.
Security contact, questionnaire scope, data-boundary statement, and no-secret evidence packet.
Security + Founder
- Next: Offer paid diligence support for questionnaire and evidence-room preparation.
- Blocked: No certification claim, breach guarantee, production connector approval, or live PHI authorization.
- Proof routes: /pilot-handoff-command, /scrimed-cyber-defense, /deployment-drift-guard
external-approval-required
Expand RCM documentation review into a structured prior-authorization readiness package.
Synthetic documentation scenario, RCM reviewer notes, and payer-policy metadata boundary.
RCM Compliance
- Next: Propose documentation completeness review and draft packet QA.
- Blocked: No payer submission, claim submission, coverage determination, reimbursement assurance, or payment execution.
- Proof routes: /pilot-handoff-command, /scrimed-clinical-benchmark-suite, /pilot-value-evidence
review-required
Convert pilot review evidence into an investor diligence appendix.
Validated proof routes, risk register, boundaries, and next milestone ledger.
Founder + Qualified Reviewer
- Next: Prepare claims-safe diligence appendix after founder and qualified review.
- Blocked: No securities material, investment advice, valuation assurance, audited financial statement, or fundraising guarantee.
- Proof routes: /pilot-handoff-command, /investor-audience-readiness, /risk-register